17.94
-0.56 (-3.03%)
| Previous Close | 18.50 |
| Open | 18.46 |
| Volume | 365,945 |
| Avg. Volume (3M) | 287,015 |
| Market Cap | 1,231,442,688 |
| Price / Book | 4.96 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2026 |
| Diluted EPS (TTM) | -0.790 |
| Total Debt/Equity (MRQ) | 0.21% |
| Current Ratio (MRQ) | 29.71 |
| Operating Cash Flow (TTM) | -41.26 M |
| Levered Free Cash Flow (TTM) | -27.93 M |
| Return on Assets (TTM) | -11.97% |
| Return on Equity (TTM) | -16.20% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | GH Research PLC | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | -0.67 |
Select this tab to load the latest available analysis.
|
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 33.88% |
| % Held by Institutions | 68.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Lynx1 Capital Management Lp | 30 Jun 2026 | 13,263,288 |
| Bvf Inc/Il | 30 Jun 2026 | 8,650,158 |
| Ra Capital Management, L.P. | 30 Jun 2026 | 7,636,813 |
| Rtw Investments, Lp | 30 Jun 2026 | 5,933,815 |
| Avoro Capital Advisors Llc | 30 Jun 2026 | 1,800,000 |
| Foresite Capital Management Vi Llc | 30 Jun 2026 | 940,493 |
| Braidwell Lp | 30 Jun 2026 | 207,240 |
| Y-Intercept (Hong Kong) Ltd | 30 Sep 2026 | 170,315 |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |